Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rossella Bertulli

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

Journal of Clinical Oncology

English

Related publications

Telangiectatic Osteosarcoma of the Extremity: Neoadjuvant Chemotherapy in 24 Cases

Acta Orthopaedica Scandinavica

2001

English

Systemic Complications of the Bidirectional Intraoperative Chemotherapy With Intravenous Ifosfamide and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Using Cisplatin Plus Doxorubicin

Pleura and Peritoneum

Internal Medicine

2019

English

Nonmetastatic Osteosarcoma of the Extremity With Pathologic Fracture at presentationLocal and Systemic Control by Amputation or Limb Salvage After Preoperative Chemotherapy

Acta Orthopaedica Scandinavica

2003

English

Conservative Treatment Followed by Chemotherapy With Doxorubicin and Ifosfamide for Cervical Sarcoma Botryoides in Young Females

British Journal of Cancer

Cancer Research

Oncology

1999

English

Ifosfamide/Etoposide Alternating With High-Dose Methotrexate: Evaluation of a Chemotherapy Regimen for Poor-Risk Osteosarcoma

British Journal of Cancer

Cancer Research

Oncology

1999

English

A Retrospective Study on Combination Therapy With Ifosfamide, Adriamycin and Cisplatin for Progressive or Recurrent Uterine Sarcoma

Molecular and Clinical Oncology

Cancer Research

Oncology

2014

English

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Journal of Clinical Oncology

English

Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial

English

Prognostic Value of HER2 to CEP17 Ratio on Fluorescence in Situ Hybridization Ratio in Patients With Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Trastuzumab

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rossella Bertulli

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

Related publications

Telangiectatic Osteosarcoma of the Extremity: Neoadjuvant Chemotherapy in 24 Cases

Systemic Complications of the Bidirectional Intraoperative Chemotherapy With Intravenous Ifosfamide and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Using Cisplatin Plus Doxorubicin

Nonmetastatic Osteosarcoma of the Extremity With Pathologic Fracture at presentationLocal and Systemic Control by Amputation or Limb Salvage After Preoperative Chemotherapy

Conservative Treatment Followed by Chemotherapy With Doxorubicin and Ifosfamide for Cervical Sarcoma Botryoides in Young Females

Ifosfamide/Etoposide Alternating With High-Dose Methotrexate: Evaluation of a Chemotherapy Regimen for Poor-Risk Osteosarcoma

A Retrospective Study on Combination Therapy With Ifosfamide, Adriamycin and Cisplatin for Progressive or Recurrent Uterine Sarcoma

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial

Prognostic Value of HER2 to CEP17 Ratio on Fluorescence in Situ Hybridization Ratio in Patients With Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Trastuzumab